O
Opya
In-home early intervention autism therapy for children
About Opya
Opya specializes in early intervention autism therapy for children from 18 months to 6 years old. The company was founded in 2015 by Jonathan Wright, who was inspired by his mother's career as an adolescent psychiatrist. His background of over 20 years in healthcare and technology led him to establish Opya to provide a better therapy option for young children with autism.
The company provides comprehensive, in-home Applied Behavior Analysis (ABA) therapy, which is complemented by telehealth services for speech, occupational, and feeding therapies. This model focuses on providing care in the child's natural environment to promote meaningful learning. Opya also offers center-based care options and uses technology to facilitate communication between clinicians, families, and staff. Its business model relies on in-network contracts with both Medicaid and commercial payers in California, making its services accessible to a wide range of families. Opya serves families across Northern and Southern California.
A significant milestone for Opya is earning a 3-year Behavioral Health Center of Excellence (BHCOE) accreditation, highlighting its commitment to clinical quality. The company has also expanded its services through acquisitions, such as the purchase of the Center for Autism Spectrum Therapy. In 2021, Opya raised $15.4 million in a Series A funding round to scale its clinical care and accelerate product innovation. Investors include Panoramic Ventures, the SB Opportunity Fund, and the Disability Opportunity Fund.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- San Mateo, United States
- Employees
- 96
- Open positions
- None listed
- Dealroom signal
- 63.6/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Investment activity
- 1 company, latest Mar 2016
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Aug 2021 | $15M | $62M | Altitude Ventures · Raven One Ventures · Panoramic Ventures · The Disability Opportunity Fund | — |
| SEEDEquity / VC | Oct 2017 | $3.9M | $16M | SpringRock Ventures | — |
Growth signals
Latest recorded traffic for Opya is 4K monthly website visits, down 25.9% over the last three months. Opya's team declined 4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
SpringRock Ventures
Series A7 investors entered at this stage
Panoramic Ventures
Altitude Ventures- RVRaven One Ventures
The Disability Opportunity Fund
SB Opportunity Fund
Divergent Investments
BIP Ventures
Other known investors1 additional known investor
LearnStart
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Opya on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Opya’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








